Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

At the top of that list, unsurprisingly, are Novo Nordisk obesity drugs Ozempic, Rybelsus, and Wegovy, all grouped together ...

Legal-Bay LLC, a leading pre settlement funding company, reports that November's $2.2 billion ruling against GlaxoSmithKline has still not been distributed to 80,000+ Zantac plaintiffs. The UK-based ...

A degree in Science, Technology, Engineering, or Mathematics (STEM) offers access to high-demand careers in innovation-driven ...

Every state in the union has criminal tax statutes.  While different states tax in different ways, most of their criminal tax efforts function very similarly to how California goes after state tax ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

Shares of GSK PLC GSK inched up 0.78% to £13.59 Friday, on what proved to be an all-around great trading session for the ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...

The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...

The U.S. government targets 15 high-cost medications for Medicare price negotiations for 2027, under the Inflation Reduction ...

Novo Nordisk's Ozempic and Wegovy are among 15 drugs targeted for Medicare price negotiations in 2027. The U.S. aims to cut ...

Potential antitrust deregulation could foster a more favourable environment for larger M&A deals in 2025, though skepticism ...